Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Krista Yordanova"'
Autor:
Krista Yordanova, Claudia Pföhler, Luca F. Schweitzer, Catherine Bourg, Leonie Adam, Thomas Vogt
Publikováno v:
Skin Health and Disease, Vol 3, Iss 1, Pp n/a-n/a (2023)
Abstract Targeted therapy with BRAF‐ and MEK‐Inhibitors (BRAFi, MEKi) provides an excellent therapeutic option for patients with malignant melanomas with a BRAF‐Mutation. Mild cutaneous adverse events have been common under the BRAF‐ and MEK
Externí odkaz:
https://doaj.org/article/a9ce18eb3c384c449e60a5681886e920
Autor:
Konstantinos Christofyllakis, Claudia Pföhler, Moritz Bewarder, Cornelia S. L. Müller, Lorenz Thurner, Torben Rixecker, Thomas Vogt, Stephan Stilgenbauer, Krista Yordanova, Dominic Kaddu-Mulindwa
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
IntroductionMultiple agents are approved in the adjuvant setting of completely resected high-risk (stages IIC–IV) malignant melanoma. Subgroups may benefit differently depending on the agent used. We performed a systematic review and meta-analysis
Externí odkaz:
https://doaj.org/article/68299114429c4768adb7887877e5b1ab
Autor:
Lorenz Thurner, Claudia Pföhler, Dominic Kaddu-Mulindwa, Moritz Bewarder, Torben Rixecker, Thomas Vogt, Cornelia S. L. Müller, Konstantinos Christofyllakis, Krista Yordanova, Stephan Stilgenbauer
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology
IntroductionMultiple agents are approved in the adjuvant setting of completely resected high-risk (stages IIC–IV) malignant melanoma. Subgroups may benefit differently depending on the agent used. We performed a systematic review and meta-analysis
Autor:
Krista Yordanova, Stephan Stilgenbauer, Rainer M. Bohle, Gunter Aßmann, Lorenz Thurner, Dominic Kaddu-Mulindwa, Vadim Lesan, Jörg Thomas Bittenbring, Matthias Scharberger, Moritz Bewarder
Publikováno v:
British Journal of Haematology. 186